Lydia Codetta Pan

Title: Lydia Codetta Pan: Innovator in Insulin Resistance Treatment

Introduction

Lydia Codetta Pan is a prominent inventor based in Mystic, Connecticut. She has made significant contributions to the field of medicine, particularly in the treatment of insulin resistance. With a total of three patents to her name, her work has the potential to impact the lives of many individuals suffering from metabolic disorders.

Latest Patents

One of Lydia's latest patents focuses on the treatment of insulin resistance in mammals. This invention outlines methods for administering an effective amount of a specific compound, referred to as formula I. The compounds are classified as growth hormone secretagogues, which are instrumental in increasing the levels of endogenous growth hormone. Additionally, the patent details certain intermediates useful in the synthesis of these compounds, along with processes for their synthesis. Another aspect of her invention involves administering a combination of a functional somatostatin antagonist and the compound of formula I to enhance treatment efficacy.

Career Highlights

Lydia Codetta Pan is currently associated with Pfizer Corporation, a leading pharmaceutical company. Her work at Pfizer has allowed her to collaborate with other talented professionals in the field, further advancing her research and innovations.

Collaborations

Some of Lydia's notable coworkers include Philip Albert Carpino and Charles Kwok-Fung Chiu. Their collaboration has contributed to the development of innovative solutions in the treatment of insulin resistance.

Conclusion

Lydia Codetta Pan's contributions to the field of medicine, particularly in the treatment of insulin resistance, highlight her role as a significant inventor. Her patents and ongoing work at Pfizer Corporation demonstrate her commitment to advancing healthcare solutions.